Comparison Overview
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.
N/A
Last Update: 25/03/2026
Bamboo represents a community of researchers, clinicians, parents, regulatory scientists, and business professionals committed to providing hope to patients suffering from debilitating disease. Bamboo is focused on some of the most devastating neurological and neuromusc...
Regeneron
777 Old Saw Mill River Road, Tarrytown, 10591, US
Last Update: 21/06/2026
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new w...
Compliance Ranges Comparison
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.
Regeneron
Benchmark & Cyber Underwriting Signals
Incidents vs Biotechnology Industry Avg (This Year)
No incidents recorded for Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. in 2026.
Incidents vs Biotechnology Industry Avg (This Year)
No incidents recorded for Regeneron in 2026.
Incident History - Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. (X = Date, Y = Severity)
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc. cyber incidents detection timeline including parent company and subsidiaries.
Incident History - Regeneron (X = Date, Y = Severity)
Regeneron cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.
Regeneron
FAQ
Latest Global CVEs
Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.
Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.
Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.
Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.
Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.